Lee's Pharmaceutical Holdings Limited (FRA:L1PA)
Germany · Delayed Price · Currency is EUR 0.1600
+0.0060 (3.90%)
Last updated: Jan 28, 2026, 9:55 AM CET
FRA:L1PA Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 97.81 | 93.1 | 16.7 | 51.28 | 1,987 | 129.32 |
Depreciation & Amortization | 101 | 99.3 | 107.95 | 125.52 | 126.97 | 124.26 |
Other Amortization | 48.43 | 48.43 | 41.55 | 26.98 | 19.9 | 3.25 |
Loss (Gain) From Sale of Assets | -0.14 | -0.14 | -41.63 | -0.24 | -0.04 | -155.66 |
Asset Writedown & Restructuring Costs | 25.91 | 25.91 | 33.31 | 2.68 | 235.09 | 6.49 |
Loss (Gain) From Sale of Investments | 0.38 | 0.38 | 1.43 | 46.36 | -2,300 | 203.47 |
Loss (Gain) on Equity Investments | 0.84 | 0.84 | 0.87 | 1.1 | 3.5 | 11.41 |
Stock-Based Compensation | 0.41 | 0.41 | 0.79 | 12.11 | 16.89 | 17.44 |
Provision & Write-off of Bad Debts | 13.7 | 13.7 | 1.28 | -0.26 | 90.28 | 1.18 |
Other Operating Activities | 130 | 11.07 | 26.16 | 33.1 | -33.8 | -50.97 |
Change in Accounts Receivable | -82.46 | -82.46 | 21.09 | 39.9 | -1.95 | 5.65 |
Change in Inventory | -7.22 | -7.22 | -61.96 | 43.28 | 43.34 | -147.46 |
Change in Accounts Payable | 69.98 | 69.98 | -26.82 | 39.48 | -11.35 | -6.51 |
Change in Other Net Operating Assets | -31.28 | -31.28 | -10.63 | -137.67 | 34.47 | 77.05 |
Operating Cash Flow | 367.35 | 242.01 | 110.08 | 283.63 | 210.68 | 218.91 |
Operating Cash Flow Growth | 182.59% | 119.85% | -61.19% | 34.63% | -3.76% | -45.27% |
Capital Expenditures | -42.37 | -43.96 | -29.43 | -17.46 | -50.7 | -138.4 |
Sale of Property, Plant & Equipment | 0.24 | 0.24 | 0.11 | 0.88 | 0.04 | 0.06 |
Cash Acquisitions | - | - | -0.02 | - | - | 0.47 |
Divestitures | - | - | - | - | - | -164.44 |
Sale (Purchase) of Intangibles | -166 | -141.54 | -110.72 | -196.37 | -320.03 | -219.74 |
Investment in Securities | -8.64 | -8.64 | -6.7 | -45.5 | -2.17 | -9.11 |
Other Investing Activities | 5.41 | 3.66 | 1.53 | 2.39 | 2.58 | 7.42 |
Investing Cash Flow | -211.36 | -190.23 | -145.22 | -256.05 | -370.28 | -523.74 |
Long-Term Debt Issued | - | 183.92 | 104.45 | 60 | 227.37 | 167.42 |
Total Debt Issued | 183.92 | 183.92 | 104.45 | 60 | 227.37 | 167.42 |
Long-Term Debt Repaid | - | -168.21 | -80.41 | -164.45 | -134.02 | -170.67 |
Total Debt Repaid | -168.21 | -168.21 | -80.41 | -164.45 | -134.02 | -170.67 |
Net Debt Issued (Repaid) | 15.71 | 15.71 | 24.04 | -104.45 | 93.35 | -3.25 |
Issuance of Common Stock | - | - | - | - | 3.54 | 0.45 |
Common Dividends Paid | -26.5 | -17.67 | -10.6 | -24.14 | -35.92 | -38.23 |
Other Financing Activities | -24.86 | - | - | - | - | 31.23 |
Financing Cash Flow | -35.65 | -1.96 | 13.44 | -128.6 | 60.97 | -9.8 |
Foreign Exchange Rate Adjustments | -7.56 | -0.51 | -0.08 | 12.79 | 0.96 | -3.68 |
Net Cash Flow | 112.78 | 49.32 | -21.77 | -88.23 | -97.67 | -318.32 |
Free Cash Flow | 324.98 | 198.06 | 80.65 | 266.18 | 159.99 | 80.52 |
Free Cash Flow Growth | 213.62% | 145.58% | -69.70% | 66.37% | 98.70% | -71.42% |
Free Cash Flow Margin | 22.62% | 14.15% | 7.66% | 21.58% | 12.64% | 6.62% |
Free Cash Flow Per Share | 0.55 | 0.34 | 0.14 | 0.45 | 0.27 | 0.14 |
Cash Interest Paid | 12.43 | 12.77 | 10.4 | 6.24 | 3.79 | 4.72 |
Cash Income Tax Paid | 11.33 | 10.61 | 9.54 | -12.88 | 64.18 | 73.19 |
Levered Free Cash Flow | 153.6 | 49.6 | -44.97 | 68.9 | -177.85 | -240.68 |
Unlevered Free Cash Flow | 161.98 | 58.24 | -37.92 | 73.04 | -175.1 | -237.31 |
Change in Working Capital | -50.99 | -50.99 | -78.33 | -15.01 | 64.52 | -71.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.